BURZYNSKI RESEARCH INSTITUTE INC (BZYR)
About BURZYNSKI RESEARCH INSTITUTE INC
BURZYNSKI RESH INSTITUTE
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2025
- $0
- Net income
- -$1.4M
- Total assets
- $847
Source: SEC EDGAR · updated Jun 8, 2026
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
Burzynski Research Institute Inc (BZYR) Stock Price
- Reported a net loss of $1.4M in FY2025.
- Trading 83% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review BURZYNSKI RESEARCH INSTITUTE INC.
Write a review
Burzynski Research Institute Inc: frequently asked questions
Is Burzynski Research Institute Inc an American company?
Burzynski Research Institute Inc is a US-based company headquartered in Houston, Texas, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Burzynski Research Institute Inc headquartered?
Burzynski Research Institute Inc is headquartered in Houston, Texas, United States.
Is Burzynski Research Institute Inc publicly traded?
Yes — Burzynski Research Institute Inc is a publicly traded company. Its stock trades under the ticker symbol BZYR on the OTC.
What does Burzynski Research Institute Inc do?
Burzynski Research Institute Inc is an American Medical Devices company in the Health & Beauty sector.
